000 | 01407cam a2200325Ii 4500 | ||
---|---|---|---|
001 | 9780429174674 | ||
008 | 180331t20162016fluad ob 001 0 eng d | ||
020 |
_a9780429174674 _q(e-book : PDF) |
||
020 |
_z9781482246131 _q(hardback) |
||
024 | 7 |
_a10.1201/b19023 _2doi |
|
035 | _a(OCoLC)930017843 | ||
040 |
_aFlBoTFG _cFlBoTFG _erda |
||
050 | 4 |
_aRM301 _b.D48 2016 |
|
082 | 0 | 4 |
_a615.1 _bD489 |
245 | 0 | 0 |
_aDevelopability of biotherapeutics : _bcomputational approaches / _cedited by Sandeep Kumar, Biotherapeutics Pharmaceutical Sciences, Pfizer, Incorporated; Satish Kumar Singh, Biotherapeutics Pharmaceutical Sciences, Pfizer, Incorporated. |
264 | 1 |
_aBoca Raton ; _aLondon : _bCRC Press, _c[2016] |
|
264 | 4 | _c©2016 | |
300 | _a1 online resource | ||
336 |
_atext _2rdacontent |
||
337 |
_acomputer _2rdamedia |
||
338 |
_aonline resource _2rdacarrier |
||
505 | 0 | _asection 1. Principles of biopharmaceutical informatics -- section 2. Developability practices in the biopharmaceutical industry. | |
650 | 0 |
_aBiological products _xTherapeutic use. _915705 |
|
650 | 0 |
_aBiopharmaceutics. _915706 |
|
700 | 1 |
_aKumar, Sandeep, _eeditor. _913421 |
|
700 | 1 |
_aSingh, S. K. _q(Satish Kumar), _d1960- _eeditor. _915707 |
|
776 | 0 | 8 |
_iPrint version: _z9781482246131 _w(DLC) 2016304840 |
856 | 4 | 0 |
_uhttps://www.taylorfrancis.com/books/9781482246155 _zClick here to view. |
942 | _cEBK | ||
999 |
_c71067 _d71067 |